This apparently opposite behaviour remains mechanistically unresolved and requires independent replication
However, limitations exist in the form of in vivo instability, the reliance on carriers that are biocompatible and robust and limited sites of application (local and direct) (Park et al
The spa is warm, welcoming and clean
Since the increase in brain BDNF is correlated with the increase in brain DHA 24 , we tested the hypothesis that plasma BDNF may be a valid biomarker for the changes in the brain DHA content
decreased TSH, decreased Total T4, and decreased Free T4) Uncommon (0.1% to 1%): Galactorrhea, hypoadrenalism, diabetes insipidus [Ref] Local Very common (10% or more): Injection site pain (13.8%), injection site reactions Common (1% to 10%): Injection site hematoma [Ref] Dermatologic Very common (10% or more): Alopecia (13.2%) Common (1% to 10%): Pruritus, bruise, rash Uncommon (0.1% to 1%): Cellulitis, petechiae, urticaria, basal cell carcinoma [Ref] Musculoskeletal Common (1% to 10%): Joint pain, backache Uncommon (0.1% to 1%): Arthritis, joint effusion, muscle pain, Raynaud's phenomenon [Ref] Psychiatric Common (1% to 10%): Depression Uncommon (0.1% to 1%): Anxiety, paranoia, libido decrease [Ref] Other Very common (10% or more): Fatigue (31.8%), generalized pain (15%) Common (1% to 10%): Weakness Uncommon (0.1% to 1%): Hearing loss, otitis [Ref] Respiratory Very common (10% or more): Upper respiratory tract infection (18.2%), sinusitis (12%) Common (1% to 10%): Cold symptoms, flu symptoms, epistaxis Uncommon (0.1% to 1%): Pneumonia, pulmonary nodule, status asthmaticus [Ref] Renal Uncommon (0.1% to 1%): Increased creatinine kinase [Ref] Hypersensitivity Uncommon (0.1% to 1%): Allergic reaction Frequency not reported : Anaphylactic reaction [Ref] Immunologic Very common (10% or more): Antibodies to octreotide (25%) Ocular Common (1% to 10%): Blurred vision, visual disturbance Uncommon (0.1% to 1%): Increased intraocular pressure [Ref] Genitourinary Common (1% to 10%): Urinary tract infection, pollakiuria Uncommon (0.1% to 1%): Gynecomastia, amenorrhea, polymenorrhea, oligomenorrhea, vaginitis, nephrolithiasis, hematuria [Ref] References 1
P., Zinovkin, R
